Bacterin International Holdings, Inc. (BIHI) Gets Approval for Listing on NYSE Amex
Bacterin International Holdings, Inc., a biologic company that engages in the research, development, manufacturing, and commercialization of bioactive coatings for medical devices, announced that its common stock has been given the nod of approval for a listing on the NYSE Amex and has chosen Knight Capital Group as its market maker. Shares for Bacterin’s common stocks will begin trading on NYSE Amex on Monday March 7, 2011 under a new ticker symbol “BONE”. "This is truly an eventful period in our company's history as we proudly commence the trading of our stock on the NYSE Amex. We believe our shares…